✉ Email this page to a colleague
« Back to Dashboard
Duopa is a drug marketed by Abbvie Inc and is included in one NDA.
The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
A generic version of DUOPA was approved as carbidopa; levodopa by MAYNE PHARMA on August 28th, 1992.
Summary for DUOPA
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||4|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for DUOPA|
|What excipients (inactive ingredients) are in DUOPA?||DUOPA excipients list|
|DailyMed Link:||DUOPA at DailyMed|
DUOPA is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting DUOPA
TREATMENT OF MOTOR FLUCTUATIONS IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE
Exclusivity Expiration: See Plans and Pricing
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Abbvie Inc||DUOPA||carbidopa; levodopa||SUSPENSION;ENTERAL||203952-001||Jan 9, 2015||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|